RxDoctor Payments Data

Gerard Vitale, MD

Vascular Surgery · Glen Cove, NYNPI 1396801759

Payments from drug & device makers

$3,321in general payments, 2019–2025

Across 48 payments — averaging $69.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Angiodynamics, Inc.$2K
  • Boston Scientific$1K
  • Smith+Nephew$139
  • Medtronic$88
  • 180 Medical, Inc.$83
  • Medline Industries LP$48
  • plus $27 from 1 others

What the payments were for

  • Travel & lodging$1,45544%
  • Food & beverage$1,86656%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Angiodynamics, Inc.2$1,750
Boston Scientific25$1,187
Smith+Nephew8$139
Medtronic5$88
180 Medical, Inc.4$83
Medline Industries LP2$48
E.r. Squibb & Sons, L.L.C.2$27

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,321 in reported general payments places this provider in the 40th percentile of 405 vascular surgery providers in New York.

See all vascular surgery providers in New York

Medicare billing

Part B allowed, 2024
$1,622,515
Medicare patients
832
Services billed
3,974

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban45$51,095
XareltoRivaroxaban33$30,966
Cilostazol50$1,260
Pentoxifylline15$413
ClopidogrelClopidogrel Bisulfate34$257
Gabapentin12$51
Diazepam28$36

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Glen Cove

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →